Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retraction Note to: A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune‑inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA‑146a expression in patients with mild‑to‑moderate ulcerative colitis.
Farsi F, Ebrahimi-Daryani N, Golab F, Akbari A, Janani L, Karimi MY, Irandoost P, Alamdari NM, Agah S, Vafa M. Farsi F, et al. Among authors: janani l. Eur J Nutr. 2022 Sep;61(6):3313. doi: 10.1007/s00394-022-02949-1. Eur J Nutr. 2022. PMID: 35767081 No abstract available.
Can coenzyme Q10 supplementation effectively reduce human tumour necrosis factor-α and interleukin-6 levels in chronic diseases? Protocol for a systematic review and meta-analysis of randomised controlled trials.
Farsi F, Heshmati J, Janani L, Irandoost P, Mesri Alamdari N, Keshtkar A, Akbari A, Vafa M. Farsi F, et al. Among authors: janani l. BMJ Open. 2017 Oct 8;7(10):e016841. doi: 10.1136/bmjopen-2017-016841. BMJ Open. 2017. PMID: 28993384 Free PMC article.
Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
Farsi F, Heshmati J, Keshtkar A, Irandoost P, Alamdari NM, Akbari A, Janani L, Morshedzadeh N, Vafa M. Farsi F, et al. Among authors: janani l. Pharmacol Res. 2019 Oct;148:104290. doi: 10.1016/j.phrs.2019.104290. Epub 2019 Jun 8. Pharmacol Res. 2019. PMID: 31185284
Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.
Safarpour P, Daneshi-Maskooni M, Vafa M, Nourbakhsh M, Janani L, Maddah M, Amiri FS, Mohammadi F, Sadeghi H. Safarpour P, et al. Among authors: janani l. BMC Fam Pract. 2020 Feb 7;21(1):26. doi: 10.1186/s12875-020-1096-3. BMC Fam Pract. 2020. PMID: 32033527 Free PMC article. Clinical Trial.
Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 - A Randomized Clinical Trial.
Khalighi Sikaroudi M, Mokhtare M, Janani L, Faghihi Kashani AH, Masoodi M, Agah S, Abbaspour N, Dehnad A, Shidfar F. Khalighi Sikaroudi M, et al. Among authors: janani l. Complement Med Res. 2020;27(5):302-309. doi: 10.1159/000506149. Epub 2020 Mar 23. Complement Med Res. 2020. PMID: 32203968 Clinical Trial. English.
Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial.
Khalighi Sikaroudi M, Mokhtare M, Shidfar F, Janani L, Faghihi Kashani A, Masoodi M, Agah S, Dehnad A, Shidfar S. Khalighi Sikaroudi M, et al. Among authors: janani l. EXCLI J. 2020 May 19;19:652-667. doi: 10.17179/excli2020-2247. eCollection 2020. EXCLI J. 2020. PMID: 33013260 Free PMC article.
A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis.
Farsi F, Ebrahimi-Daryani N, Golab F, Akbari A, Janani L, Karimi MY, Irandoost P, Alamdari NM, Agah S, Vafa M. Farsi F, et al. Among authors: janani l. Eur J Nutr. 2021 Sep;60(6):3397-3410. doi: 10.1007/s00394-021-02514-2. Epub 2021 Feb 23. Eur J Nutr. 2021. Retraction in: Eur J Nutr. 2022 Sep;61(6):3313. doi: 10.1007/s00394-022-02949-1. PMID: 33620550 Retracted. Clinical Trial.
153 results